Dispute Resolution Pilot Holds Promise Despite Slow Uptake – FDAer
This article was originally published in The Tan Sheet
Executive Summary
FDA has received "positive feedback" from industry on its dispute resolution pilot for manufacturing site inspections, but will meet with various trade groups in September to discuss why firms are not participating
You may also be interested in...
FDA GMP Initiative Shifts Warning Letter Review Back To Centers
The Center for Drug Evaluation & Research will begin reviewing GMP warning letters March 1 as part of FDA's initiative to create a risk-based approach to pharmaceutical manufacturing
GMP Dispute Resolution System Under Development By FDA; PAT Is Impetus
FDA is planning to create a dispute resolution system for manufacturing inspections
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC